Terms: = Brain cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2
91 results:
1. Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
Van Genechten T; De Laere M; Van den Bossche J; Stein B; De Rycke K; Deschepper C; Hazes K; Peeters R; Couttenye MM; Van De Walle K; Roelant E; Maes S; Vanden Bossche S; Dekeyzer S; Huizing M; Caluwaert K; Nijs G; Cools N; Verlooy J; Norga K; Verhulst S; Anguille S; Berneman Z; Lion E
BMJ Open; 2024 Mar; 14(3):e077613. PubMed ID: 38503417
[TBL] [Abstract] [Full Text] [Related]
2. Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Cao W; Lan J; Hu C; Kong J; Xiang L; Zhang Z; Sun Y; Zeng Z; Lei S
Aging (Albany NY); 2024 Mar; 16(6):5618-5633. PubMed ID: 38499392
[TBL] [Abstract] [Full Text] [Related]
3. An immune signature to predict the prognosis of
Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features of five cases of CIC::DUX4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
5. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
[TBL] [Abstract] [Full Text] [Related]
6. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC-rearranged sarcoma.
Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A
Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887
[TBL] [Abstract] [Full Text] [Related]
7. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall.
Kojima N; Arai Y; Satomi K; Kubo T; Matsushita Y; Mori T; Matsushita H; Ushijima T; Yatabe Y; Shibata T; Yonemori K; Ichimura K; Ichikawa H; Kawai A; Yoshida A
Mod Pathol; 2022 Oct; 35(10):1439-1448. PubMed ID: 35440765
[TBL] [Abstract] [Full Text] [Related]
8. Diffusion and perfusion imaging biomarkers of H3 K27M mutation status in diffuse midline gliomas.
Kathrani N; Chauhan RS; Kotwal A; Kulanthaivelu K; Bhat MD; Saini J; Prasad C; Chakrabarti D; Santosh V; Uppar AM; Srinivas D
Neuroradiology; 2022 Aug; 64(8):1519-1528. PubMed ID: 35083503
[TBL] [Abstract] [Full Text] [Related]
9. A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies.
Fu S; Piccioni DE; Liu H; Lukas RV; Kesari S; Aregawi D; Hong DS; Yamaguchi K; Whicher K; Zhang Y; Chen YL; Poola N; Eddy J; Blum D
Sci Rep; 2021 Nov; 11(1):22355. PubMed ID: 34785698
[TBL] [Abstract] [Full Text] [Related]
10. Cholesterol is required for transcriptional repression by BASP1.
Loats AE; Carrera S; Fleming AF; Roberts ARE; Sherrard A; Toska E; Moorhouse AJ; Medler KF; Roberts SGE
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34266955
[TBL] [Abstract] [Full Text] [Related]
11. Maintenance of wt1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with wt1 peptide vaccine immunotherapy.
Yokota C; Kagawa N; Takano K; Chiba Y; Kinoshita M; Kijima N; Oji Y; Oka Y; Sugiyama H; Tsuboi A; Izumoto S; Kishima H; Hashimoto N
Cancer Immunol Immunother; 2022 Jan; 71(1):189-201. PubMed ID: 34089373
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic Validation of a Clinical Laboratory-Oriented Targeted RNA Sequencing System for Detecting Gene Fusions in Hematologic Malignancies.
Lim HJ; Lee JH; Lee SY; Choi HW; Choi HJ; Kee SJ; Shin JH; Shin MG
J Mol Diagn; 2021 Aug; 23(8):1015-1029. PubMed ID: 34082071
[TBL] [Abstract] [Full Text] [Related]
13. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract] [Full Text] [Related]
14. Branched Multipeptide-combined Adjuvants Potentially Improve the Antitumor Effects on Glioblastoma.
Tran TA; Kim YH; Jung S; Kim IY; Moon KS; Jang WY; Lee HJ; Lee JJ; Jung TY
J Immunother; 2021 May; 44(4):151-161. PubMed ID: 33512855
[TBL] [Abstract] [Full Text] [Related]
15. BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/
Li L; Meng Q; Li G; Zhao L
Biomed Res Int; 2020; 2020():8628695. PubMed ID: 33426068
[TBL] [Abstract] [Full Text] [Related]
16. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.
Lopez-Nunez O; Cafferata B; Santi M; Ranganathan S; Pearce TM; Kulich SM; Bailey KM; Broniscer A; Rossi S; Zin A; Nasrallah MP; Li MM; Zhong Y; Miele E; Alaggio R; Surrey LF
Brain Pathol; 2021 Jan; 31(1):70-83. PubMed ID: 32997853
[TBL] [Abstract] [Full Text] [Related]
17. wt1 Clone 6F-H2 Cytoplasmic Expression Differentiates Astrocytic Tumors from Astrogliosis and Associates with Tumor Grade, Histopathology, IDH1 Status, Apoptotic and Proliferative Indices: A Tissue Microarray Study.
Abd El-Hafez A; Ismail Hany HSED
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2403-2413. PubMed ID: 32856872
[TBL] [Abstract] [Full Text] [Related]
18. Glioma-derived extracellular vesicles promote tumor progression by conveying wt1.
Tsutsui T; Kawahara H; Kimura R; Dong Y; Jiapaer S; Sabit H; Zhang J; Yoshida T; Nakada M; Hanayama R
Carcinogenesis; 2020 Sep; 41(9):1238-1245. PubMed ID: 32463428
[TBL] [Abstract] [Full Text] [Related]
19. Long Noncoding RNA wt1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.
Qiu G; Tong W; Jiang C; Xie Q; Zou J; Luo C; Zhao J; Zhang L; Zhao J
Technol Cancer Res Treat; 2020; 19():1533033820919759. PubMed ID: 32419643
[TBL] [Abstract] [Full Text] [Related]
20. Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1.
Kim YH; Tran TA; Duong TH; Jung S; Kim IY; Moon KS; Jang WY; Lee HJ; Lee JJ; Jung TY
Hum Vaccin Immunother; 2020 Nov; 16(11):2840-2848. PubMed ID: 32401608
[TBL] [Abstract] [Full Text] [Related]
[Next]
